197 related articles for article (PubMed ID: 9583725)
1. Co-expression of osteopontin and CD44v9 in gastric cancer.
Ue T; Yokozaki H; Kitadai Y; Yamamoto S; Yasui W; Ishikawa T; Tahara E
Int J Cancer; 1998 Apr; 79(2):127-32. PubMed ID: 9583725
[TBL] [Abstract][Full Text] [Related]
2. [Expression of osteopontin splice variant and its clinical significance in gastric cancer].
Sun X; Wang L; Hou W; Li Y; Liu L; Zuo W; Yu J
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):427-30. PubMed ID: 26463145
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin expression in a group of lymph node negative breast cancer patients.
Tuck AB; O'Malley FP; Singhal H; Harris JF; Tonkin KS; Kerkvliet N; Saad Z; Doig GS; Chambers AF
Int J Cancer; 1998 Oct; 79(5):502-8. PubMed ID: 9761120
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
5. [Expression of osteopontin mRNA and its clinical significance in gastric cancer].
Sun XJ; Zuo WS; Ma H; Hou WH; Cai SP; Jiang XH
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):292-5. PubMed ID: 15996323
[TBL] [Abstract][Full Text] [Related]
6. [Osteopontin expression and its relation to invasion and metastases in gastric cancer].
Zhang DT; Yuan J; Yang L; Guo XN; Hao ZM; Han ZY; Wu KC; Fan DM
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):167-9. PubMed ID: 15946568
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin expression and distribution in human carcinomas.
Brown LF; Papadopoulos-Sergiou A; Berse B; Manseau EJ; Tognazzi K; Perruzzi CA; Dvorak HF; Senger DR
Am J Pathol; 1994 Sep; 145(3):610-23. PubMed ID: 8080043
[TBL] [Abstract][Full Text] [Related]
9. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
10. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
11. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
[TBL] [Abstract][Full Text] [Related]
12. Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer.
Ozmen F; Ozmen MM; Ozdemir E; Moran M; Seçkin S; Guc D; Karaagaoglu E; Kansu E
World J Gastroenterol; 2011 Jul; 17(27):3220-8. PubMed ID: 21912471
[TBL] [Abstract][Full Text] [Related]
13. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
[TBL] [Abstract][Full Text] [Related]
14. CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer.
Go SI; Ko GH; Lee WS; Kim RB; Lee JH; Jeong SH; Lee YJ; Hong SC; Ha WS
Cancer Res Treat; 2016 Jan; 48(1):142-52. PubMed ID: 25779358
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.
Tuck AB; O'Malley FP; Singhal H; Tonkin KS; Harris JF; Bautista D; Chambers AF
Arch Pathol Lab Med; 1997 Jun; 121(6):578-84. PubMed ID: 9199622
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin expression in primary sarcomas of the pulmonary artery.
Gaumann A; Petrow P; Mentzel T; Mayer E; Dahm M; Otto M; Kirkpatrick CJ; Kriegsmann J
Virchows Arch; 2001 Nov; 439(5):668-74. PubMed ID: 11764388
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
Lopez CA; Hoyer JR; Wilson PD; Waterhouse P; Denhardt DT
Lab Invest; 1993 Sep; 69(3):355-63. PubMed ID: 8377476
[TBL] [Abstract][Full Text] [Related]
19. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of osteopontin in gastric cancer.
Imano M; Satou T; Itoh T; Sakai K; Ishimaru E; Yasuda A; Peng YF; Shinkai M; Akai F; Yasuda T; Imamoto H; Okuno K; Ito H; Shiozaki H; Ohyanagi H
J Gastrointest Surg; 2009 Sep; 13(9):1577-82. PubMed ID: 19582521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
